Kronos Bio (KRON)
US Market

Kronos Bio (KRON) Stock Price & Analysis


KRON Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.20 - $5.74
Previous Close$1.69
Average Volume (3M)314.34K
Market Cap
Enterprise Value-$98.03M
Total Cash (Recent Filing)$226.40M
Total Debt (Recent Filing)$30.98M
Price to Earnings (P/E)-0.8
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.18
Shares Outstanding57,630,464
10 Day Avg. Volume213,207
30 Day Avg. Volume314,339
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)0.45
Price to Sales (P/S)81.16
Price to Cash Flow (P/CF)-4.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-81.69
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.80
Price Target Upside521.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kronos Bio’s price range in the past 12 months?
Kronos Bio lowest stock price was $1.20 and its highest was $5.74 in the past 12 months.
    What is Kronos Bio’s market cap?
    Currently, no data Available
    When is Kronos Bio’s upcoming earnings report date?
    Kronos Bio’s upcoming earnings report date is Aug 10, 2023 which is in 68 days.
      How were Kronos Bio’s earnings last quarter?
      Kronos Bio released its earnings results on May 10, 2023. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.445 by -$0.015.
        Is Kronos Bio overvalued?
        According to Wall Street analysts Kronos Bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Kronos Bio pay dividends?
          Kronos Bio does not currently pay dividends.
          What is Kronos Bio’s EPS estimate?
          Kronos Bio’s EPS estimate is -$0.48.
            How many shares outstanding does Kronos Bio have?
            Kronos Bio has 57,630,463 shares outstanding.
              What happened to Kronos Bio’s price movement after its last earnings report?
              Kronos Bio reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.445. Following the earnings report the stock price went down -2.762%.
                Which hedge fund is a major shareholder of Kronos Bio?
                Among the largest hedge funds holding Kronos Bio’s share is Omega Fund Management, LLC. It holds Kronos Bio’s shares valued at 6M.


                  Kronos Bio Stock Smart Score

                  The Kronos Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Kronos Bio

                  Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.


                  Top 5 ETFs holding KRON

                  Market Value
                  Smart Score
                  Schwab U.S. Broad Market ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold KRON. The ETFs are listed according to market value of KRON within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  ImmunoCellular Therapeutics
                  Capricor Therapeutics
                  Praxis Precision Medicines
                  Peak Bio
                  Spero Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis